WINNINGHAM RICK E (Chief Executive Officer) reported 3 transactions at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/21/2025ACC: 0001302443-25-000008
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-56.82K
Net shares
Net seller
$1.02M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
9.90K acquired · 66.72K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−9.90K
Price / share
—
Trade value
—
% of position
0.6%
11/19/2025
1.72M→1.71M
Ordinary Shares
Indirect
Shares
+9.90K
Price / share
—
Trade value
—
% of position
73.3%
11/19/2025
13.50K→23.40K
Ordinary Shares
Direct
Shares
−56.82K
Price / share
$17.90
Trade value
$1.02M
% of position
3.3%
11/20/2025
1.71M→1.65M
Total
Net shares
−56.82K
Net value
-$1.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/19/2025 | G · Gift | −9.90K | — | — | 0.6% | 1.72M | 1.71M |
| Ordinary Shares Indirect | 11/19/2025 | G · Gift | +9.90K | — | — | 73.3% | 13.50K | 23.40K |
| Ordinary Shares Direct | 11/20/2025 | F · Tax Withholding | −56.82K | $17.90 | $1.02M | 3.3% | 1.71M | 1.65M |
| Total | −56.82K | -$1.02M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned92.57K
Total
92.57K indirect92.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Total | 92.57K | 92.57K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported